BACKGROUND: Emerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma. OBJECTIVES: We sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma. METHODS: We examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis. RESULTS: In a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1β into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1β or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1β- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1β on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1β and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1β levels, and lactate content correlated negatively with lung function. CONCLUSIONS: Collectively, these findings demonstrate that IL-1β/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.
BACKGROUND: Emerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma. OBJECTIVES: We sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma. METHODS: We examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis. RESULTS: In a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1β into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1β or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1β- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1β on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1β and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1β levels, and lactate content correlated negatively with lung function. CONCLUSIONS: Collectively, these findings demonstrate that IL-1β/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.
Authors: Weimin Liu; Sucai Liu; Mukesh Verma; Iram Zafar; James T Good; Donald Rollins; Stephen Groshong; Magdalena M Gorska; Richard J Martin; Rafeul Alam Journal: J Allergy Clin Immunol Date: 2016-10-01 Impact factor: 10.793
Authors: Jane E Tully; James D Nolin; Amy S Guala; Sidra M Hoffman; Elle C Roberson; Karolyn G Lahue; Jos van der Velden; Vikas Anathy; Timothy S Blackwell; Yvonne M W Janssen-Heininger Journal: Am J Respir Cell Mol Biol Date: 2012-05-31 Impact factor: 6.914
Authors: Jonathan Jantsch; Dipshikha Chakravortty; Nadine Turza; Alexander T Prechtel; Björn Buchholz; Roman G Gerlach; Melanie Volke; Joachim Gläsner; Christina Warnecke; Michael S Wiesener; Kai-Uwe Eckardt; Alexander Steinkasserer; Michael Hensel; Carsten Willam Journal: J Immunol Date: 2008-04-01 Impact factor: 5.422
Authors: Cristen Pantano; Jennifer L Ather; John F Alcorn; Matthew E Poynter; Amy L Brown; Amy S Guala; Stacie L Beuschel; Gilman B Allen; Laurie A Whittaker; Mieke Bevelander; Charles G Irvin; Yvonne M W Janssen-Heininger Journal: Am J Respir Crit Care Med Date: 2008-02-08 Impact factor: 21.405
Authors: Oscar R Colegio; Ngoc-Quynh Chu; Alison L Szabo; Thach Chu; Anne Marie Rhebergen; Vikram Jairam; Nika Cyrus; Carolyn E Brokowski; Stephanie C Eisenbarth; Gillian M Phillips; Gary W Cline; Andrew J Phillips; Ruslan Medzhitov Journal: Nature Date: 2014-07-13 Impact factor: 69.504
Authors: Caroline Dive; Christopher J Morrow; Radosław Polański; Cassandra L Hodgkinson; Alberto Fusi; Daisuke Nonaka; Lynsey Priest; Paul Kelly; Francesca Trapani; Paul W Bishop; Anne White; Susan E Critchlow; Paul D Smith; Fiona Blackhall Journal: Clin Cancer Res Date: 2013-11-25 Impact factor: 12.531
Authors: Cheryl van de Wetering; Reem Aboushousha; Allison M Manuel; Shi B Chia; Cuixia Erickson; Maximilian B MacPherson; Jos L van der Velden; Vikas Anathy; Anne E Dixon; Charles G Irvin; Matthew E Poynter; Albert van der Vliet; Emiel F M Wouters; Niki L Reynaert; Yvonne M W Janssen-Heininger Journal: J Immunol Date: 2020-01-10 Impact factor: 5.422
Authors: Madeleine M Mank; Leah F Reed; Camille J Walton; Madison L T Barup; Jennifer L Ather; Matthew E Poynter Journal: Am J Physiol Lung Cell Mol Physiol Date: 2021-12-22 Impact factor: 5.464
Authors: Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock Journal: J Innate Immun Date: 2019-11-29 Impact factor: 7.349
Authors: Katherine E Menson; Madeleine M Mank; Leah F Reed; Camille J Walton; Katherine E Van Der Vliet; Jennifer L Ather; David G Chapman; Bradford J Smith; Mercedes Rincon; Matthew E Poynter Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-08-12 Impact factor: 5.464
Authors: Diana C Contreras Healey; Jacqueline Y Cephus; Sierra M Barone; Nowrin U Chowdhury; Debolanle O Dahunsi; Matthew Z Madden; Xiang Ye; Xuemei Yu; Kellen Olszewski; Kirsten Young; Valerie A Gerriets; Peter J Siska; Ryszard Dworski; Jonathan Hemler; Jason W Locasale; Masha V Poyurovsky; R Stokes Peebles; Jonathan M Irish; Dawn C Newcomb; Jeffrey C Rathmell Journal: J Immunol Date: 2021-02-08 Impact factor: 5.422
Authors: Reem Aboushousha; Evan Elko; Shi B Chia; Allison M Manuel; Cheryl van de Wetering; Jos van der Velden; Maximilian MacPherson; Cuixia Erickson; Julie A Reisz; Angelo D'Alessandro; Emiel F M Wouters; Niki L Reynaert; Ying-Wai Lam; Vikas Anathy; Albert van der Vliet; David J Seward; Yvonne M W Janssen-Heininger Journal: FASEB J Date: 2021-05 Impact factor: 5.834